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Nodular regenerative hyperplasia (NRH) of the liver is often associated with rheumatologic or lymphoproliferative disorders and
a cause of portal hypertension in some patients. We report the case of a 71-year-old patient with celiac disease and unexplained
portal hypertension. Biopsy of the liver revealed NRH as the underlying cause. The patient did not suﬀer from an autoimmune,
rheumatologic or lymphoproliferative disease. A thrombophilic disorder that might cause NRH was ruled out. Celiac disease is
often associated with mild elevation of liver enzymes and steatosis of the liver, but the association with NRH was described in only
a few patients. We discuss the possible relationship of celiac disease and NRH.
1.Introduction
Nodular regenerative hyperplasia (NRH) of the liver is
histologically characterized by an atrophy of the hepatocytes
in the central areas and compensatory proliferation of the
hepatocytes in portal regions. The occlusion of small portal
vein branches is considered to be the basic lesion; however,
the exact pathogenesis is not known [1]. Nodular regen-
erative hyperplasia is frequently associated with underlying
lymphoproliferative or rheumatological disorders; an asso-
ciation with drugs like azathioprine has also been described
[1]. Liver function is usually well preserved in patients with
NRH, but portal hypertension might be present at least in
some of the aﬀected patients.
Gluten-sensitive enteropathy is associated with mild liver
abnormalities like hypertransaminasemia in up to 40% of
patients [3], but more severe involvement of the liver is rare
and usually resolves on a gluten-free diet [4].
Wedescribeapatientwithlong-standing, sofarunrecog-
nised gluten-sensitive enteropathy, NRH, and severe por-
tal hypertension. The possible causes for the relationship
between NRH and gluten-sensitive enteropathy are dis-
cussed.
2.CaseReport
The 71-year-old male patient was admitted to our hospital
for further diagnostic workup of microcytic anemia. The
patient complained of fatigue during the last months but
denied any signs of gastrointestinal bleeding. He did not
report weight loss, nor did he complain of any gastrointesti-
nal symptoms like diarrhoea or steatorrhea.
Physical examination showed an anemic but well nour-
ished patient in good health. The spleen was not palpa-
ble. The laboratory workup revealed moderate microcytic
anemia (Hb 9.0g/dL, MCV 71fL) and a low ferritin
(8ng/mL, normal range 30–400ng/mL). The transaminases
were mildly elevated (GOT 50U/L, GPT 51U/L, normal
range 9–38U/L, and 10–41U/L, resp.). Bilirubin, γGT as
well as the prothrombin time were within normal ranges.
Tests for hepatitis B and C and autoantibody tests (antinu-
clear, antineutrophil cytoplasmatic, antimitochondrial, anti-
smooth muscle) were all negative.
Liver ultrasound as well as liver NMR revealed mild
ﬁbrosis/steatosis,butnosignsofcirrhosis.Theportal,splenic
and the superior mesenteric veins were all dilated but patent.
A recanalised umbilical vein was present. Spleen-size was in
the normal range.2 Case Reports in Gastrointestinal Medicine
Upper endoscopy revealed esophageal varices grade III
with cherry red spots but no signs of recent bleeding.
Because of the anemia, a duodenal biopsy was taken and
showed short villi along with epithelial cell damage and a
dense lymphoplasmacellular inﬁltrate of the lamina propria.
The ﬁndings were diagnostic for celiac sprue. In addition,
IgA antitransglutaminase antibodies were highly positive
(82U/mL, normal range <5U/mL).
For further workup of the unexplained portal hyperten-
sion and the mildly elevated transaminases, a percutaneous
liver biopsy was done. Histology showed steatosis of the liver
and the typical ﬁndings of nodular regenerative hyperplasia
(Figure 1). In addition, a thrombophilia screen was per-
formed but revealed no abnormalities (assays for proteins
C and S, antithrombin III, IgA, IgG, IgM anticardiolipin
antibodies (aCL), Factor V Leiden, prothrombin-G20210A-
mutation, homocysteine levels were all negative).
The patient was put on a gluten-free diet and medical
treatment with propranolol for primary prophylaxis of
bleeding from esophageal varices was started. Six months
later, the haemoglobin level and the transaminases were in
the normal range.
3. Discussion
We describe a patient with portal hypertension, mild
liver abnormalities, and anemia caused by gluten-sensitive
enteropathy and NRH.
Portalhypertensionanditscomplicationslikeesophageal
varices and ascites are often present in patients with NRH
[1, 2]. The liver function is generally preserved and liver
functions test are normal or only slightly abnormal. In a
high percentage of aﬀected patients, the diagnosis of NRH
is missed on imaging procedures like ultrasound, computed
tomography or magnetic resonance imaging [5–7]. A liver
biopsy is mandatory for diagnosis, but even on a routine
needle biopsy, the diagnosis is missed in some patients [8].
Nodular regenerative hyperplasia of the liver is charac-
terized by nodules in varying sizes which replace the normal
liver parenchyma. On histology, NRH is distinguished from
cirrhosis of the liver by the absence of ﬁbrosis, the sepa-
ration of nodules of regenerating hepatocytes by atrophic
parenchyma and the curvilinear compression of the central
veins by regenerating nodules [9].
The most accepted pathophysiologic concept for the
development of NRH is the diminished perfusion of small
branches of the portal venous system. The decreased blood
ﬂow causes atrophy of the hepatocytes in central areas that
is compensated by hepatocyte proliferation in portal regions
[1]. However, the exact pathomechanism is not known.
Nodular regenerative hyperplasia is a disease that aﬀects
mainly patients who are 50 years or older. The disease is
often associated with rheumatologic or lymphoproliferative
disorders. In addition, autoimmune disorders like Sj¨ ogren’s
syndrome, autoimmune thyroid disease, and rheumatoid
arthritis [10, 11] are associated with celiac sprue. The
incidence of autoimmune disorders is signiﬁcantly higher in
patients with longstanding, untreated, or poorly controlled
coeliacdisease[12].Familialformsoranassociationwiththe
Figure 1: Initial nodular regenerative hyperplasia of the liver with
localised fatty degeneration.
Budd-Chiari-syndrome have also been described [13, 14].
An association with drugs like thioguanine, busulfan, and
azathioprine is also known.
Furthermore, a number of thrombophilic disorders like
polycythemia vera, protein S deﬁciency [15], and IgG
antiphospholipid syndrome [16] are associated with NRH.
To our best knowledge, there are only a few patients
with NRH and concomitant coeliac disease reported in
the literature [17–19]. Austin and coworkers described two
patients with refractory celiac disease and NRH who were
positive for IgA anticardiolipin antibodies (aCL) [17]. The
authors postulated that gluten-speciﬁc T cells drive an
IgA autoantibody response to both transglutaminase and
protein/phospholipid complexes leading to the formation of
IgA aCL, causing high local IgA aCL concentrations in the
portal vein of these patients. This high local concentration
of IgA aCL is considered to increase the risk of thrombus
formation in small branches of the portal vein. More than
10% of patients with celiac disease are positive for IgG or
IgM aCL [20]. If the presence of aCL is the link (or the
cause) between coeliac disease and NRH, one would suspect
a higher prevalence of systemic thrombosis and/or NRH in
patients with celiac disease. Recently, we reported a young
patient with celiac disease, NRH, and portal hypertension
who was, like the actual patient, negative for IgA aCL
antibodies [19]. In contrast to the actual patient, who was
newly diagnosed and was therefore not on a gluten-free diet,
the previously reported young patient was on a gluten-free
diet for a long time and responded well to the diet. Since
both of our patients had no IgA aCL antibodies they diﬀered
widely with respect to age, disease duration, and gluten-free
diet, the proposed association between these factors and IgA
aCL antibodies does appear unlikely.
In conclusion, we can only speculate on the pathophysi-
ological link between NRH and celiac disease in our patient.
Since we were not able to detect IgA aCL antibodies in both
of our patients, we think that—at least in some patients with
celiac disease—IgA aCL antibodies in the portal system are
not the pathophysiological basis of NRH in patients with
gluten sensitive enteropathy.Case Reports in Gastrointestinal Medicine 3
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